Name | KRAS G12C inhibitor 31 |
---|
Description | KRAS G12C inhibitor 31 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 1. KRAS G12C inhibitor 31 can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
Target |
KRAS G12C[1] |
References |
[1]. Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1. |
Molecular Formula | C25H22ClFN6O3 |
---|---|
Molecular Weight | 508.93 |